RhumbLine Advisers’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-52,824
Closed -$322K 3049
2021
Q3
$322K Buy
52,824
+1,884
+4% +$11.5K ﹤0.01% 2740
2021
Q2
$419K Sell
50,940
-2,932
-5% -$24.1K ﹤0.01% 2645
2021
Q1
$482K Sell
53,872
-6,170
-10% -$55.2K ﹤0.01% 2516
2020
Q4
$693K Buy
60,042
+6,940
+13% +$80.1K ﹤0.01% 2304
2020
Q3
$553K Sell
53,102
-6,158
-10% -$64.1K ﹤0.01% 2244
2020
Q2
$779K Buy
59,260
+9,992
+20% +$131K ﹤0.01% 2149
2020
Q1
$388K Sell
49,268
-44
-0.1% -$347 ﹤0.01% 2276
2019
Q4
$1.02M Buy
49,312
+1,653
+3% +$34.2K ﹤0.01% 2073
2019
Q3
$653K Buy
47,659
+1,202
+3% +$16.5K ﹤0.01% 2227
2019
Q2
$571K Buy
46,457
+2,140
+5% +$26.3K ﹤0.01% 2308
2019
Q1
$553K Sell
44,317
-1,249
-3% -$15.6K ﹤0.01% 2292
2018
Q4
$516K Buy
45,566
+14,713
+48% +$167K ﹤0.01% 2287
2018
Q3
$577K Sell
30,853
-2,375
-7% -$44.4K ﹤0.01% 2224
2018
Q2
$859K Sell
33,228
-184
-0.6% -$4.76K ﹤0.01% 2079
2018
Q1
$749K Sell
33,412
-250
-0.7% -$5.6K ﹤0.01% 2063
2017
Q4
$843K Sell
33,662
-385
-1% -$9.64K ﹤0.01% 2020
2017
Q3
$823K Sell
34,047
-236
-0.7% -$5.71K ﹤0.01% 2070
2017
Q2
$693K Buy
34,283
+80
+0.2% +$1.62K ﹤0.01% 2148
2017
Q1
$920K Buy
34,203
+6,825
+25% +$184K ﹤0.01% 1976
2016
Q4
$521K Buy
27,378
+7,175
+36% +$137K ﹤0.01% 2207
2016
Q3
$395K Buy
20,203
+3,130
+18% +$61.2K ﹤0.01% 2339
2016
Q2
$255K Buy
17,073
+3,585
+27% +$53.5K ﹤0.01% 2623
2016
Q1
$124K Buy
13,488
+125
+0.9% +$1.15K ﹤0.01% 2858
2015
Q4
$258K Buy
13,363
+1,800
+16% +$34.8K ﹤0.01% 2665
2015
Q3
$172K Buy
11,563
+648
+6% +$9.64K ﹤0.01% 2838
2015
Q2
$239K Buy
+10,915
New +$239K ﹤0.01% 2786